Four-year persistence patterns among patients initiating therapy with the angiotensin II receptor antagonist losartan versus other antihypertensive drug classes-Reference-Cited by-同舟云学术

Four-year persistence patterns among patients initiating therapy with the angiotensin II receptor antagonist losartan versus other antihypertensive drug classes

Published:2001-12 Issue:12 Volume:23 Page:1999-2010
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Conlin Paul R.,Gerth William C.,Fox James,Roehm James B.,Boccuzzi Stephen J.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference31 articles.

1. Effects of treatment and morbidity in hypertension;JAMA,1967

2. Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials;Moser;J Am Coll Cardiol,1996

3. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis;Psaty;JAMA,1997

4. Continuation of initial antihypertensive medication after 1 year of therapy;Bloom;Clin Ther,1998

5. The dropout problem in anti-hypertensive treatment. A pilot study of social and emotional factors influencing a patient's ability to follow antihypertensive treatment;Caldwell;J Chronic Dis,1970

Cited by 155 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of cardiocerebrovascular disease incidence between angiotensin converting enzyme inhibitor and angiotensin receptor blocker users in a real-world cohort;Journal of Applied Biomedicine;2023-04-01

2. Gerontology Issues in Cardiology Practice;Kardiologiia;2019-12-17

3. A review of the prescribing trend of thiazide‐type and thiazide‐like diuretics in hypertension: A UK perspective;British Journal of Clinical Pharmacology;2019-12

4. Determinants and Barriers to Adherence in Hypertension;Drug Adherence in Hypertension and Cardiovascular Protection;2018

5. Improving Adherence to Treatment and Reducing Economic Costs of Hypertension: The Role of Olmesartan-Based Treatment;High Blood Pressure & Cardiovascular Prevention;2017-07-10